Private Placements





Hedge Funds





AiM Medical Robotics Inc.




Business: Automated, real-time neurosurgical targeting and therapy.


Industry/Market: $6.3B global neurological surgery market, with more than 500,000 procedures in functional neurosurgery and neuro oncology. Errors in targeting, device placement, or therapy delivery can limit results or create adverse events. Accuracy to the millimeter level is critical to reducing the risk of errors, streamlining workflow, and reducing procedure time while limiting costly errors.


Status: The AiM Medical Robotics System is designed to provide high levels of precision, automation, and efficiency by introducing automated, real-time targeting and therapy delivery both in the conventional surgical suite or in the MRI suite.




The proprietary technology is licensed from Worcester Polytechnic Institute. The system is compact & portable, with remote capability. MRI-compatibility provides for real-time procedures. There is a self-learning interface with procedural tools (AI), and haptic feedback and trajectory control of the insertion device. The Company has partnered with Triple Ring Technologies, a leading design and development firm.




The AiM prototype system has passed significant bench and animal tests and has been successfully used in an IRB-controlled human study at Brigham and Womens Hospital (Boston).




$14M (non-dilutive) funding to date in NIH and NCI grants.




3 issued patents, 8 pending.






Robert Cathcart, President & CEO. Hansen Robotics, Clear Guide Medical.




Gregory Fischer, PHD, chief Scientific Officer, Founder, & Co-Inventor. Director of Automation & Interventional Medicine Robotics Lab, Worcester Polytechnic Institute.




Julie Pilitsis, MD, Chair of the Medical Advisory Board, Founder, & Co-Inventor. Chair of & Professor, Department of Neuroscience & Experimental Therapeutics, Albany Medical College.




Gus Castello, QC Manufacturing Advisor. Intuitive Surgical, Cognos-Lux.


An Experienced Medical Advisory Board: Six members, including individuals from University of California, San Francisco; The Cleveland Clinic Foundation; Emory University; and Northwestern University Memorial Hospital.


Offering: Early round financing.




Offices: 401 E. Las Olas Blvd., Suite 1421, Fort Lauderdale, FL 33301.


Contact: Robert Cathcart, CEO/President, at 862.703.0254 or




Index of Private Placements & Hedge Funds




Here is a link to information on our comprehensive investor awareness program.

For more detailed information, please contact one of the following individuals:


William J. Ritger at 561.891.1903 or

David Goodboy at 561.349.7300 or



The Deal Flow section of this website is operated jointly by Palm Beach Hedge Fund Association, Inc., a Florida corporation, and TickerBuzz, LLC, a Florida limited liability company. Neither PBHFA nor TickerBuzz are registered broker-dealers, and they do not give investment advice, endorsement, analysis, or recommendations with respect to any securities. All securities listed here are being offered by, and all information included on this site is the responsibility of the applicable issuer of such securities. Neither PBHFA nor TickerBuzz have taken any steps to verify the adequacy, accuracy, or completeness of any information, and neither PBHFA nor TickerBuzz nor any of their officers, directors, agents, and employees make any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. By accessing this site and any pages thereof, you agree to be bound by the PBHFA Terms of Use and Privacy Policy. Neither PBHFA nor TickerBuzz make investment recommendations, and no communication, through this website or in any other medium, should be construed as a recommendation for any security offered on or off this investment platform. Equity crowdfunding investments in private placements, and start-up investments in particular, are speculative and involve a high degree of risk, and those investors who cannot afford to lose their entire investment should not invest in start-ups. Companies seeking startup investments through equity crowdfunding tend to be in earlier stages of development, and their business model, products, and services may not yet be fully developed, operational, or tested in the public marketplace. There is no guarantee that the stated valuation and other terms are accurate or in agreement with the market or industry valuations. Additionally, investors may receive illiquid and/or restricted stock that may be subject to holding period requirements and/or liquidity concerns. In the most sensible investment strategy for start-up investing, start-ups should only be part of your overall investment portfolio. Further, the start-up portion of your portfolio may include a balanced portfolio of different start-ups. Investments in start-ups are highly illiquid, and those investors who cannot hold an investment for the long term (at least 5-7 years) should not invest.


This Profile is intended for discussion purposes only; the only definitive source of information regarding this offering is the Company offering documents. This Profile is not a solicitation to buy or sell any security, and must not be relied upon for financial, legal, tax, or any other professional advice. Investor prospects should also carefully research and consider the risks inherent in this investment. The information in this Profile is applicable only as of the date of this Profile and is subject to change without prior notice. Past performance is not indicative of future results. The editor of this Profile is a Managing Member of TickerBuzz. This Company has not paid any fee for this Company Profile. Neither PBHFA nor TickerBuzz take any compensation relating to the success of any securities offering. October 29, 2020.




Web Hits